Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Jefferies Downgrades NGM Biopharmaceuticals to Hold

Jefferies Downgrades NGM Biopharmaceuticals to Hold

Jefferies analyst Dennis Ding downgrades NGM Biopharmaceuticals (NASDAQ:NGM) from Buy to Hold.

byBenzinga Newsdesk

October 17, 2022

1 minute read

Jefferies analyst Dennis Ding downgrades NGM Biopharmaceuticals (NASDAQ:NGM) from Buy to Hold.

Investor Sentiment Drops Following Economic Reports

By Lisa Levin

July 7, 2:18 AM

The CNN Money Fear and Greed index showed some a decline in overall sentiment among U.S. investors on Thursday. The Dow Jones dropped more than 300 points on Thursday as investors assessed the recent economic data.

AZZ

News

What’s Going On With JD.Com Stock?

By Henry Khederian

November 16, 11:34 AM

JD.Com Inc (NASDAQ: JD) shares are trading lower by 5.3% to $27.07 Thursday morning.

BABA

Disney Box Office Troubles: Will 2023 Be The First Year Since 2014 To Miss This Major Milestone?

By Chris Katje

July 6, 4:45 PM

Mass media and entertainment conglomerate The Walt Disney Company (NYSE: DIS) has seen shares fall in 2023 amid worries about its box office, streaming platform and advertising revenue.

DIS